Data in Brief (Jun 2023)

Dataset on safety and protective efficacy studies of COVID-19 vaccine candidates based on structurally modified plant virus in female hamsters

  • A.O. Kovalenko,
  • E.M. Ryabchevskaya,
  • E.A. Evtushenko,
  • O.A. Kondakova,
  • P.A. Ivanov,
  • M.V. Arkhipenko,
  • N.A. Nikitin,
  • O.V. Karpova

Journal volume & issue
Vol. 48
p. 109158

Abstract

Read online

This data article is related to the previous research, which addressed the development of a COVID-19 recombinant vaccine candidate. Here, we present the additional data in support of the safety and protective efficacy evaluation of two COVID-19 vaccine candidates based on the coronaviruses’ S protein fragments and a structurally modified plant virus – spherical particles. The effectiveness of the experimental vaccines was studied against the SARS-CoV-2 virus in an in vivo infection model in female Syrian hamsters. The body weight of vaccinated laboratory animals was monitored. The histological assessment data of the infected with the SARS-CoV-2 virus hamsters’ lungs are provided.

Keywords